What Is the EPDS and Who It's For
The Edinburgh Postnatal Depression Scale (EPDS) represents a validated 10-item screening questionnaire specifically designed to identify postpartum depression and related mood disorders in women during the first postpartum year. Developed by Cox, Holden, and Sagovsky in 1987 and since validated across multiple cultural and linguistic contexts, the EPDS has become the internationally recommended screening instrument for perinatal depression in both clinical and research settings. The scale exists in the public domain, allowing free utilization by healthcare systems and individuals without licensing restrictions.
Postpartum depression fundamentally differs from "baby blues," a temporary and expected emotional state occurring in 50–80% of women in the immediate postpartum period. Baby blues typically manifest as mood lability, tearfulness, irritability, and anxiety beginning 2–5 days after delivery, peaking at approximately day 10, and spontaneously resolving within 2 weeks without intervention. These transient mood changes reflect the dramatic hormonal shifts accompanying delivery and typically cause minimal functional impairment.
Postpartum depression, by contrast, represents a major depressive disorder meeting standard diagnostic criteria that develops within 4 weeks of delivery (though depression can develop up to 12 months postpartum and still be classified as perinatal mood disorder). Research suggests that postpartum depression affects 10–15% of women in developed countries and up to 20% in developing regions. Unlike baby blues, postpartum depression persists beyond 2 weeks, causes significant distress, impairs functioning in childcare and daily activities, and requires professional treatment for symptom resolution.
The EPDS screens for depressed mood, anxiety, anhedonia (inability to experience pleasure), guilt, worthlessness, and suicidal ideation. The scale does not diagnose postpartum depression—clinical diagnosis requires evaluation by qualified mental health professionals—but rather identifies women with symptom patterns suggesting significant mood disturbance warranting professional assessment. If you're experiencing anxiety symptoms alongside depression, consider using the anxiety self-assessment tool to clarify whether anxiety or mood disturbance is predominant. Research suggests that EPDS scores of 10 or higher demonstrate 87–100% sensitivity for major depression, meaning this score appropriately identifies most women with clinically significant depression while minimizing false negatives.
This screening tool applies to women within the first 12 months postpartum, though research suggests sensitivity remains optimal during the first 3 months. Women who experienced depression or anxiety during pregnancy, have personal history of mental illness, experienced traumatic delivery, lack adequate social support, or experienced recent major life stressors face elevated postpartum depression risk and particularly benefit from EPDS screening.
How to Take This Screening
Carefully read each of the 10 questions and select the response option that best describes how you have felt over the past 7 days. Be honest in your responses—there are no "correct" answers, and candid responses enable accurate assessment. The screening requires approximately 5 minutes to complete.
The EPDS measures feelings and thoughts rather than behaviors or circumstances. For example, one question asks "I have felt scared or in panic for no very good reason," reflecting the anxiety component common in postpartum mood disorders. Another item addresses "I have had thoughts of harming myself" to identify suicidal ideation requiring immediate professional intervention.
After completing all 10 questions, sum your individual responses to obtain a total EPDS score. Scores range from 0–30, with higher scores indicating greater depression severity. Once you obtain your total score, consult the interpretation section to understand your results and appropriate next steps.
Important note: This screening provides preliminary assessment only and does not constitute medical diagnosis. Individuals with concerning responses—particularly those endorsing suicidal ideation or harm thoughts—need to contact healthcare providers or crisis services immediately rather than relying on calculator interpretation alone.
Understanding Your Score
Interpretation of EPDS scores follows evidence-based cutoffs developed through research validating the scale across diverse populations. Review your total score within the following framework:
| EPDS Score | Interpretation | Clinical Significance | Recommended Action |
|---|---|---|---|
| 0–8 | Not likely postpartum depression | Low probability of clinically significant depression | Routine follow-up with obstetric provider; repeat screening at next visit if risk factors present |
| 9–11 | Possible postpartum depression | Moderate probability warranting professional assessment | Schedule appointment with mental health provider or obstetric provider; discuss symptoms and concerns |
| 12–13 | High possibility postpartum depression | Substantial probability of clinically significant depression | Urgent appointment with mental health provider or obstetric provider for comprehensive evaluation |
| 14 or higher | Probable postpartum depression | High probability of major depression requiring treatment | Immediate evaluation by mental health provider; may warrant urgent or same-day assessment |
Scores of 0–8 suggest that while you may experience some stress or mood fluctuation—entirely normal in the postpartum period—symptoms likely do not meet criteria for postpartum depression. Guidelines recommend that women with scores in this range receive routine follow-up during standard postpartum visits. However, if you develop additional concerning symptoms between visits or your mood worsens, repeat screening or contact your healthcare provider.
Scores of 9–11 indicate possible postpartum depression warranting professional evaluation. Guidelines recommend scheduling an appointment with your obstetric provider or a mental health professional to discuss your symptoms comprehensively. These scores suggest sufficient symptom burden to warrant clinical assessment, though diagnostic confirmation requires professional evaluation considering your complete clinical presentation, duration of symptoms, functional impairment, and personal context. Do not delay seeking evaluation based on this score range.
Scores of 12–13 represent a high possibility threshold where research suggests substantial probability of clinically significant depression meeting diagnostic criteria. Guidelines recommend that you contact your obstetric provider or mental health provider promptly for professional evaluation. Many practices recommend same-day or next-day appointments for women with scores in this range. If you cannot obtain prompt professional evaluation, consider contacting crisis services listed below.
Scores of 14 or higher indicate probable postpartum depression meeting diagnostic criteria for major depressive disorder. Guidelines recommend immediate professional evaluation, ideally within 24–48 hours. If your score falls in this range and you cannot arrange prompt clinical assessment, contact Postpartum Support International or the Crisis Text Line for guidance and resources. High EPDS scores combined with endorsement of suicidal ideation warrant emergency evaluation via emergency department or crisis line.
PPD Risk Factors and Warning Signs
While postpartum depression can develop in any woman regardless of background or circumstances, research identifies specific factors that substantially increase depression risk. Personal history of depression or anxiety during or before pregnancy represents the strongest predictor of postpartum depression, with studies demonstrating that women with prior mental illness episodes show 2–3 fold increased risk. Similarly, depressive or anxious symptoms during pregnancy substantially predict postpartum mood disorder; the burnout quiz identifies whether you're experiencing exhaustion-related mood disturbance.
Pregnancy and delivery complications increase postpartum depression risk. Women experiencing traumatic birth experiences—including emergency cesarean delivery, severe perineal trauma, neonatal complications, or situations where maternal or fetal safety was compromised—demonstrate elevated depression risk. Additionally, women delivering preterm infants or those whose newborns required intensive care demonstrate increased postpartum depression incidence, likely reflecting both the acute stress of neonatal complications and subsequent parenting demands with medically fragile infants.
Lack of adequate social support represents a modifiable risk factor strongly associated with postpartum depression. Research suggests that women with limited partner involvement, estrangement from family support, social isolation, or limited friendships face elevated depression risk. Conversely, women with consistent emotional and practical support—including help with household tasks, childcare assistance, and emotional validation—demonstrate substantially lower postpartum depression rates. Cultural or family circumstances limiting support availability create vulnerability.
Hormonal factors contribute to postpartum depression risk in ways incompletely understood but increasingly recognized as important. The dramatic decline in estrogen and progesterone following placental delivery triggers mood changes in susceptible individuals. Additionally, women with history of premenstrual dysphoric disorder demonstrate elevated postpartum depression risk, suggesting sensitivity to hormonal fluctuations. Thyroid dysfunction developing postpartum, particularly postpartum thyroiditis, increases mood disorder risk through metabolic and immune mechanisms; the thyroid function calculator can help identify thyroid-related contributors to postpartum mood disturbance.
Additional risk factors include major life stressors occurring during pregnancy or the postpartum period (financial hardship, housing instability, relationship conflict, loss), insufficient sleep (though distinguishing sleep deprivation consequence from depression-related sleep disruption often proves challenging), and limited access to healthcare. Understanding pregnancy weight gain science and proper nutrition during pregnancy and postpartum supports recovery. Additionally, women from marginalized communities—including racial and ethnic minorities, LGBTQ+ individuals, and immigrant populations—often face structural barriers to care access, cultural stigma around mental health treatment, and systemic discrimination increasing postpartum depression vulnerability.
Warning signs suggesting postpartum depression include persistent sad, empty, or hopeless mood lasting beyond 2 weeks postpartum; loss of interest in activities previously enjoyed; difficulty bonding with infant; negative thoughts about infant care ability; intrusive thoughts about harming oneself or the infant; severe anxiety or panic attacks; difficulty sleeping despite opportunity for rest; significant appetite changes; extreme fatigue or lack of motivation; and difficulty concentrating or making decisions. Importantly, research suggests that postpartum depression frequently accompanies severe anxiety and even obsessive-compulsive symptoms, not merely "sadness." Women experiencing persistent intrusive thoughts about harm, excessive reassurance-seeking, or overwhelming worry should seek professional evaluation.
Treatment and Support Options
Postpartum depression responds effectively to evidence-based treatments including psychotherapy, medication, and combined approaches. Research suggests that cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT) both demonstrate efficacy for postpartum depression. CBT helps identify and modify negative thought patterns and behavioral patterns maintaining depression. IPT focuses on relationship issues, role transitions, grief, and social support that may contribute to depression. Both approaches demonstrate effectiveness even in research studies of brief, limited-session formats (8–12 sessions), though more intensive treatment may benefit some individuals.
Antidepressant medications effectively treat postpartum depression, with selective serotonin reuptake inhibitors (SSRIs) generally considered first-line pharmacotherapy. Guidelines recommend that women considering medication discuss specific drug choices, dosing, potential side effects, and breastfeeding compatibility with their prescribing provider. Research on many antidepressants demonstrates minimal infant exposure through breast milk, with many SSRIs considered compatible with breastfeeding. However, individual circumstances vary, and personalized risk-benefit discussion with prescribers informs optimal treatment selection.
Combination approaches—psychotherapy combined with medication—demonstrate superior outcomes compared to either modality alone in research studies, particularly for moderate to severe depression. Additionally, lifestyle modifications including prioritization of sleep (obtained through partner support or family assistance), social connection, physical activity when feasible, and stress reduction techniques support recovery.
Support groups specifically designed for postpartum mood disorders provide valuable community, normalization, and practical coping strategies. Many hospitals, obstetric practices, and community mental health agencies sponsor postpartum depression support groups where women meet regularly to share experiences, discuss challenges, and learn from others navigating similar difficulties. Postpartum Support International, detailed below, maintains directories of support groups and online communities facilitating connection.
Hormone replacement therapy has been investigated as treatment for postpartum depression, with some research suggesting benefit, though current evidence remains insufficient to recommend hormone therapy as standard treatment. Women interested in exploring hormone-based approaches can discuss rationale, expected timeline for benefit, and monitoring requirements with qualified providers.
When PPD Becomes an Emergency
Postpartum psychosis, though rare (affecting 0.1–0.2% of women after delivery), represents a psychiatric emergency requiring immediate hospitalization. Postpartum psychosis differs fundamentally from postpartum depression in that it involves loss of contact with reality, including hallucinations or delusions. Women experiencing postpartum psychosis may hear voices, experience visual or tactile hallucinations, develop fixed false beliefs (delusions), or feel paranoia. Postpartum psychosis typically develops acutely, often within the first 2 weeks postpartum, and constitutes a medical emergency.
Suicidal ideation accompanying postpartum depression, particularly when accompanied by specific suicide plans, access to means, or prior suicide attempts, warrants emergency evaluation. Guidelines recommend that any woman expressing suicidal thoughts contact emergency services, go to the nearest emergency department, or utilize crisis resources immediately. Research suggests that suicide represents a leading cause of postpartum death in developed countries, making suicide risk assessment and emergency intervention critical.
Thoughts of harming the infant, if they involve intent or planning, also warrant emergency evaluation. Important distinction: Many women with postpartum OCD experience intrusive thoughts about harming their infants without any genuine desire or intent to harm. These distressing intrusive thoughts typically respond well to therapy. However, if thoughts of harm develop alongside significant depression, hopelessness, or loss of impulse control, emergency evaluation becomes essential. Uncertainty about the distinction between intrusive thoughts and genuine intent to harm justifies emergency consultation to ensure infant safety.
Severe symptoms preventing basic self-care or infant care—including inability to eat, drink, bathe, or tend to infant hygiene and feeding—suggest depression severity warranting urgent rather than routine evaluation. Additionally, if you experience confusion, disorientation, or inability to understand what is happening around you, seek emergency evaluation immediately.
FAQ
How soon after delivery can postpartum depression develop, and how long does it last?
Research suggests that postpartum depression typically develops within 4 weeks of delivery, though mood disorders developing up to 12 months postpartum still fall within the perinatal mood disorder classification. Average untreated depression duration spans 3–6 months, though symptoms may persist longer without intervention. With evidence-based treatment including therapy and medication, most women experience significant symptom improvement within 4–8 weeks, though full recovery may require longer. Early identification and treatment initiation substantially shortens recovery duration.
Can breastfeeding worsen postpartum depression?
Breastfeeding itself does not cause postpartum depression. However, circumstances surrounding breastfeeding—including sleep disruption from frequent nursing, stress from breastfeeding difficulties or insufficient supply, and the significant physical and emotional demands of exclusive feeding responsibility—may contribute to depression risk. Additionally, some women experience dysphoria (unexplained sadness or anxiety) specifically during milk letdown, possibly reflecting hormonal mechanisms. If breastfeeding becomes a source of significant stress or distress, discuss concerns with healthcare providers. Many women with postpartum depression successfully breastfeed with appropriate support; others choose formula feeding. The priority remains maternal mental health alongside infant nourishment.
Is postpartum depression a sign that I am a bad mother or incapable of parenting?
Postpartum depression is a medical condition resulting from neurobiological, hormonal, genetic, and environmental factors—none of which reflect parenting capability or character. Research demonstrates that women with postpartum depression love their infants deeply and worry significantly about their wellbeing, often experiencing guilt that they are not the mother they wish to be. Depression impairs motivation, energy, and emotional capacity without reflecting core parenting values or commitment. With treatment, most women experience dramatic improvements in mood and reconnection with their infants. Seeking help represents responsible parenting prioritizing family wellbeing.
Will antidepressants affect my ability to bond with my baby?
Research suggests that appropriately treated depression actually facilitates bonding better than untreated depression. Maternal depression can interfere with mother-infant interaction and bonding through reduced responsiveness, flat affect, and emotional unavailability. Treatment restoring maternal mood and emotional engagement supports optimal bonding. Most antidepressants used in the postpartum period demonstrate minimal infant exposure through breast milk and do not interfere with bonding when used in appropriate doses. Some women report that medication improves their ability to be present, engaged, and emotionally available with their infants.
How do I know if what I'm experiencing is postpartum depression or just normal stress?
Normal postpartum period includes stress, fatigue, and mood variability as women adjust to newborn care and major life changes. However, postpartum depression involves persistent (lasting beyond 2 weeks) depressed mood, loss of interest in previously enjoyed activities, guilt or worthlessness, marked functional impairment, and often anxiety. Consider the following distinctions: normal postpartum adjustment improves gradually; postpartum depression typically worsens or persists without improvement. Normal stress feels manageable most days; depression makes everything feel overwhelming. Normal fatigue improves with rest; depression-related fatigue persists despite adequate rest. If uncertainty exists, the EPDS screening and professional consultation provide definitive assessment.
Crisis Resources
Postpartum Support International (PSI)
- Phone: 1-800-944-4773 (call or text, available Monday–Friday 10 AM–2 PM EST)
- Website: postpartum.net
- Services: Comprehensive support line with trained volunteers who have personal experience with postpartum mood disorders, emergency coordination, support group directory, medication information, and family member resources
- Access: Free, confidential, judgement-free support available to all women, regardless of insurance or ability to pay
Crisis Text Line
- Method: Text HOME to 741741
- Availability: 24/7/365
- Services: Text-based crisis support allowing communication in ways some find more comfortable than voice calls
- Benefit: Particularly valuable during nighttime when other services may have limited availability
988 Suicide & Crisis Lifeline
- Numbers: Call or text 988
- Availability: 24/7/365
- Services: Free, confidential support for anyone experiencing suicidal thoughts, mental health crises, or emotional distress
- Reach: Connects directly to trained crisis specialists who can assess safety and coordinate emergency response if needed
National Maternal Mental Health Hotline
- Phone: 1-833-243-5746
- Availability: Monday–Friday 9 AM–5 PM EST (with plans to expand to 24/7)
- Services: Trained maternal mental health specialists providing information, resources, and referrals for perinatal mood disorders
If You Are in Immediate Danger
- Call 911 or go to your nearest emergency department
- Tell emergency personnel you are experiencing suicidal thoughts, thoughts of harming your infant, or postpartum psychosis
- Emergency departments provide immediate psychiatric evaluation and safety planning
Sources
Cox, J. L., Holden, J. M., & Sagovsky, R. (1987). Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150, 782-786.
American College of Obstetricians and Gynecologists. (2018). Screening and diagnosis of depression during and after pregnancy (Committee Opinion No. 757). Obstetrics & Gynecology, 132(5), e208-e212.
Wisner, K. L., Chambers, C., & Sit, D. K. (2006). Postpartum depression: A major public health problem. JAMA, 296(15), 1946-1948.
Wisner, K. L., Sit, D. K., McShea, M. C., et al. (2013). Onset timing, thoughts of self-harm, and diagnoses in postpartum depression with psychotic features. JAMA Psychiatry, 70(5), 490-498.
O'Brien, B., Naber, S., & Akagi, K. (1992). An exploratory study of postpartum depression screening tools. JOGNN, 21(3), 191-197.
Gavin, N. I., Gaynes, B. N., Lohr, K. N., Meltzer-Brody, S., Gartlehner, G., & Swinson, T. (2005). Perinatal depression: A systematic review of prevalence and incidence. Obstetrics & Gynecology, 106(5), 1071-1083.
Medical Disclaimer: This screening tool and article provide general educational information about postpartum depression and do not constitute medical diagnosis or treatment. The EPDS screening tool assists in identifying women who may benefit from professional evaluation but cannot diagnose postpartum depression or related mental health conditions. Diagnosis requires comprehensive evaluation by qualified mental health professionals (psychiatrists, psychologists, clinical social workers) or trained obstetric providers. This tool is not a substitute for professional psychiatric assessment, mental health treatment, or emergency care. Women expressing suicidal ideation, thoughts of harming themselves or others, or postpartum psychosis symptoms require immediate professional evaluation via emergency services. Do not delay seeking emergency care based on this screening tool. If you are in crisis, immediately call 911 or contact crisis resources listed above.
Related Calculators & Resources: